These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 861452)

  • 41. Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies.
    DeNardo GL; Mahe MA; DeNardo SJ; Macey DJ; Mirick GR; Erwin WD; Groch MW
    Nucl Med Commun; 1993 Jul; 14(7):587-95. PubMed ID: 8355919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Follow-up study of patients treated by iodine-131 therapy in hyperthyroidism].
    Sasaki T; Sakamoto K; Hoshino F
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Aug; 47(8):1076-81. PubMed ID: 3696965
    [No Abstract]   [Full Text] [Related]  

  • 43. Microscopic dose distributions due to iodine isotopes in thyroid.
    Reddy AR; Kaul A
    Radiat Environ Biophys; 1978 Oct; 15(3):229-39. PubMed ID: 746118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iodine-131 therapy of hyperthyroidism in pediatric patients.
    Clark JD; Gelfand MJ; Elgazzar AH
    J Nucl Med; 1995 Mar; 36(3):442-5. PubMed ID: 7884506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J; Kubinyi J; Telička Z
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concerning the usual dose of I-131 to ablate thyroid.
    Lewis CL
    J Nucl Med; 1978 Mar; 19(3):332. PubMed ID: 632915
    [No Abstract]   [Full Text] [Related]  

  • 47. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary?
    Bajnok L; Mezosi E; Nagy E; Szabo J; Sztojka I; Varga J; Galuska L; Leovey A
    Thyroid; 1999 Sep; 9(9):865-9. PubMed ID: 10524564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy).
    Bianchi L; Baroli A; Lomuscio G; Pedrazzini L; Pepe A; Pozzi L; Chiesa C
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):515-21. PubMed ID: 23358404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage.
    Hernández-Jiménez S; Pachón-Burgos A; Aguilar-Salinas CA; Andrade V; Reynoso R; Ríos A; Reza-Albarrán AA; Mehta R; González-Treviño O; Gómez-Pérez FJ; Pérez-Enríquezi B; Rull JA
    Arch Med Res; 2007 Feb; 38(2):185-9. PubMed ID: 17227727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long term follow up of patients treated for hyperthyroidism with low dose radioactive iodine.
    Blair AL; Lowe DC; Hadden DR; Weaver JA; Montgomery DA
    Ulster Med J; 1980; 49(1):71-8. PubMed ID: 7394928
    [No Abstract]   [Full Text] [Related]  

  • 51. Ask the doctor. I have hyperthyroidism and my doctor wants me to undergo radioactive iodine treatment. Its seems a bit scary. Must I do it?
    Robb-Nicholson C
    Harv Womens Health Watch; 2012 Aug; 19(12):2. PubMed ID: 23038828
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies.
    DeNardo DA; DeNardo GL; Yuan A; Shen S; DeNardo SJ; Macey DJ; Lamborn KR; Mahe M; Groch MW; Erwin WD
    J Nucl Med; 1996 Dec; 37(12):1970-5. PubMed ID: 8970516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
    Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Results of treatment of hyperthyroidism with 125-iodine].
    Glanzmann C; Horst W
    Nucl Med (Stuttg); 1975 Aug; 14(3):207-18. PubMed ID: 1208203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physical and radiobiological bases of the use of 125I in the management of thyrotoxicosis.
    Reddy AR
    Radiat Environ Biophys; 1976 Oct; 13(3):205-14. PubMed ID: 790444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ablative radioiodine therapy for hyperthyroidism.
    Wahlberg P
    Br Med J (Clin Res Ed); 1984 Nov; 289(6455):1381. PubMed ID: 6437558
    [No Abstract]   [Full Text] [Related]  

  • 58. Ablative radioiodine therapy for hyperthyroidism: a long term follow up study.
    Young RE; Hedley AJ
    Br Med J (Clin Res Ed); 1984 Sep; 289(6448):829. PubMed ID: 6434100
    [No Abstract]   [Full Text] [Related]  

  • 59. High marks for hyperthyroid therapies.
    Check W
    JAMA; 1978 Oct; 240(17):1832-3. PubMed ID: 691184
    [No Abstract]   [Full Text] [Related]  

  • 60. The early follow-up of 131I-treatment of thyrotoxicosis.
    Solheim DM; Daae LN
    Eur J Nucl Med; 1983; 8(4):185. PubMed ID: 6861789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.